← Back
$AGL All transactions

agilon health, inc.

A

$ Value

$0

Shares

75,000

Price

$0

Filed

Apr 3

Insider

Name

Schwaneke Jeffrey A.

Title

Chief Financial Officer

CIK

0001446919

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

140,342

Footnotes

Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. | The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. | Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. | Includes restricted stock units. | The amount of securities beneficially owned reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

Filing Info

Accession No.

0001628280-26-023770

Form Type

4

Issuer CIK

0001831097

Schwaneke Jeffrey A.'s History

Date Ticker Type Value
2026-04-01 AGL F $16K
2026-04-01 AGL A $0
2026-01-10 AGL A $0
2025-07-01 AGL F $110K
2025-05-28 AGL F $22K

Other Insiders at AGL (90d)

Insider Bought Sold Last
Wulf John William $51K 2025-11-12
Schwaneke Jeffrey A.
Chief Financial Officer
2026-04-01
Venkatachaliah Girish
Chief Technology Officer
2026-04-15
Shaker Benjamin
Chief Markets Officer
2026-04-15
Gertsch Timothy
Chief Accounting Officer
2026-04-15
Zamore Denise
Chief Legal Officer
2026-04-15